Market Overview

UPDATE: J.P. Morgan Reiterates Overweight Rating, Lowers PT on Agilent Technologies on F1Q13 Review

Share:
Related A
Unusual Covered Call Opportunity In Agilent
Agios Reports New, Final Data from Phase 1 Multiple Ascending Dose (MAD) Study in Healthy Volunteers for AG-348, an Investigational Medicine for Pyruvate Kinase (PK) Deficiency

In a report published Friday, J.P. Morgan reiterated its Overweight rating on Agilent Technologies (NYSE: A), but slightly lowered its price target from $51.00 to $50.00.

J.P. Morgan noted, “As a diversified supplier to the life sciences, chemical analysis, and electronic test & measurement industries, Agilent should continue to benefit from favorable long-term trends in EMG and above-market growth in both LSG and CAG, driven by higher than average investments in R&D, a strong footprint in faster growing markets (i.e., China), and synergies from recent acquisitions (i.e., Varian and Dako).”

Agilent Technologies closed on Thursday at $44.58.

Latest Ratings for A

DateFirmActionFromTo
May 2015JefferiesMaintainsBuy
May 2015BairdMaintainsNeutral
Mar 2015UBSInitiates Coverage onNeutral

View More Analyst Ratings for A
View the Latest Analyst Ratings

Posted-In: J.P. MorganAnalyst Color Price Target Analyst Ratings

 

Related Articles (A)

Get Benzinga's Newsletters